Get Complete Import-Export Data
Please Note: We only provide US Import & Export trade data. We aren’t dealing in logistics or product sale & purchase.
Explore live import data of US pharmaceuticals imports at port Boston-massachusetts and get insights of USA pharmaceuticals import statistics, date, quantity, product description, HS code, port, country, and pharmaceuticals importers and buyers database. This comprehensive trade data and import intelligence report helps businesses track supply chain trends, evaluate competitor activity, and uncover new opportunities in the USA-Boston-massachusetts import trade.
Date
14/May/2024
HS Code
Product Description
PHARMACEUTICALS HIGH VALUE
Origin Country
Unloading Port
Quantity
96
Unit
PCS
Weight
3232
Importer Name
Date
14/May/2024
HS Code
Product Description
PHARMACEUTICALS HIGH VALUE
Origin Country
Unloading Port
Quantity
430
Unit
PCS
Weight
10725
Importer Name
Date
08/Aug/2023
HS Code
Product Description
24 PALLETS TOTAL PHARMACEUTICALS MICARDIS AMLO, LTAB 28 80+10MG BLI EC MICARDIS PLUS, TABS 28 80+12.5MG EC BATCH: 23E0837, 23E0241, 23D2437 HS-CODE: 30049000 TEMPERATURE TO BE MAIN- TAINED AT PLUS 20 DEGREES CELSIUS THE WHOLE TRANSPORT
Origin Country
Unloading Port
Quantity
24
Unit
PCS
Weight
3711
Importer Name
The pharmaceuticals import data includes shipment-level details such as HS code, origin country, unloading port boston massachusetts, product descriptions, quantity or weight, date of arrival, and importer names.
Yes, you can filter by HS code to locate exactly the type of pharmaceuticals products imported into the US through Port boston massachusetts.
According to recent records, pharmaceuticals imports through Port boston massachusetts come from countries like China, Vietnam, Thailand, Belgium, Guatemala, Germany, and others.
The database provides the recent & frequently updated data on pharmaceuticals import shipments arriving at Port boston massachusetts under the relevant HS codes.
Businesses can use the data to identify active pharmaceuticals importers in the US, analyse trade flows, monitor origin-country supply patterns, assess demand and competition, and make informed decisions based on real pharmaceuticals import trends.